Bliss GVS Pharma Ltd. (BLISSGVS-BE): Bliss GVS Pharma Share Price Rises 5% to Rs 690.4
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Bliss GVS Pharma Share Price rose today to Rs 690.4, up 5% from the previous close of Rs 657.55, with the company’s market capitalisation at Rs 7,234.73 crore. The move places Bliss GVS Pharma Ltd. in focus for Bliss GVS Pharma Share Price Today, even though the supplied data does not establish a company-specific catalyst. What the verified numbers do show is a clear same-day price rise, a turnover of Rs 0.26 crore and a close at the day’s high of Rs 690.4. In today’s Indian Stock Market context, that makes the stock one of the notable Stocks in News on a facts-only basis.
For readers tracking Bliss GVS Pharma Stock News, the main question is not only what the share price did, but what the underlying financial and sector data say about the move. Univest is framing the event around price action, fundamentals, sector comparison and peer positioning rather than speculation. That approach keeps the discussion aligned with the verified Bliss GVS Pharma Share Price update and avoids attributing a cause where none is supplied.
Bliss GVS Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 690.4 |
| Previous Close | Rs 657.55 |
| Today's Move | Rs 32.85 (+5%) |
| Open | Rs 669.9 |
| High | Rs 690.4 |
| Low | Rs 657.55 |
| Turnover | Rs 0.26 crore |
| Market Capitalisation | Rs 7,234.73 crore |
| Market Cap Category | Mid Cap |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) rose to Rs 690.4 from the previous close of Rs 657.55, a move of Rs 32.85 or 5%. The stock opened at Rs 669.9, reached a high of Rs 690.4, recorded a low of Rs 657.55.
Bliss GVS Pharma Share Price Today moved from Rs 657.55 to Rs 690.4, a rise of Rs 32.85 or 5%. The stock opened at Rs 669.9, touched an intraday low of Rs 657.55 and finished at Rs 690.4, which is also the day high. That sequence confirms a strong same-day price rise within the available data.
The turnover stood at Rs 0.26 crore. On its own, that is a factual traded-value metric and should not be read as a behavioural signal. The verified data confirms the share price rise, the day’s range and the closing level, but it does not establish why the move occurred. For Bliss GVS Pharma Share Price readers, this is the key market update for today.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,234.73 crore |
| P/E Ratio | 51.34x |
| P/B Ratio | 5.67x |
| ROE | 12.11% |
| ROCE | 17.4% |
| EPS | Rs 12.81 |
| Book Value Per Share | Rs 115.94 |
| Dividend Yield | 0.23% |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 51.34x, P/B 5.67x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.
Bliss GVS Pharma Ltd. has a market capitalisation of Rs 7234.73 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 51.34x, P/B at 5.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 115.94, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 51.34x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 5.67x |
| Benchmark Median P/B | 3x |
| Company ROE | 12.11% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 17.4% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 7,234.73 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.34x, which is above the benchmark median of 32.62x, a difference of +57.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.74%, a difference of +3.15%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.63%, a difference of +27.66%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.34x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 7,234.73 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Bliss GVS Pharma
- Bliss GVS Pharma Share Price rose 5% today to Rs 690.4 from Rs 657.55.
- The stock closed at its day high of Rs 690.4 after opening at Rs 669.9.
- Market capitalisation stands at Rs 7,234.73 crore, which is above the sector median in the supplied benchmark.
- P/E is 51.34 and P/B is 5.67, both above the industry median in the supplied snapshot.
- ROE of 12.11%, ROCE of 17.4%, EPS of Rs 12.81 and book value of Rs 115.94 provide a clear fundamental frame.
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data confirms its listed identity on NSE and BSE, while the valuation and return profile indicate a business that is being assessed through both earnings and book-value lenses. For readers following Bliss GVS Pharma Share Price, the company belongs to a sector where returns, margins and valuation multiples can differ significantly across companies.
The most relevant company facts in this article are the current price, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value and dividend yield. Together they show how the market is pricing the business relative to its reported fundamentals. Univest uses this company overview to keep Bliss GVS Pharma Stock News rooted in verified figures rather than market noise.
Track Bliss GVS Pharma Share Price on Univest
Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Bliss GVS Pharma Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare the stock with sector peers, review valuation metrics and follow future Bliss GVS Pharma Share Price Today movements in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Bliss GVS Pharma share price rise today?
Ans. The data confirms that Bliss GVS Pharma Share Price rose 5% today, but it does not establish a company-specific catalyst. The verified figures only show the price move, day range, turnover and closing level.
What is Bliss GVS Pharma share price today?
Ans. Bliss GVS Pharma Share Price today is Rs 690.4. It rose Rs 32.85, or 5%, from the previous close of Rs 657.55 and ended at the day’s high. The previous close was Rs 657.55.
What is Bliss GVS Pharma market capitalisation?
Ans. Bliss GVS Pharma has a market capitalisation of Rs 7,234.73 crore. That places the company above the supplied sector median market cap and below the industry average in the benchmark snapshot.
How is Bliss GVS Pharma valued on P/E and P/B?
Ans. Bliss GVS Pharma trades at a P/E of 51.34 and a P/B of 5.67. Both are above the supplied industry median, which gives the current Bliss GVS Pharma Share Price a richer valuation context.
What do EPS and book value show for Bliss GVS Pharma?
Ans. EPS is Rs 12.81 and book value is Rs 115.94. EPS reflects earnings per share, while book value shows accounting net worth per share, both useful for evaluating Bliss GVS Pharma Share Price.
How does Bliss GVS Pharma compare with healthcare peers?
Ans. Bliss GVS Pharma’s market cap is smaller than Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its P/E is above some peers and below others, showing mixed relative valuation.
What does the sector snapshot say about Bliss GVS Pharma?
Ans. The sector snapshot shows Bliss GVS Pharma above the industry median on P/E and P/B, while ROE and ROCE are also above the benchmark midpoints. That gives the Bliss GVS Pharma Share Price a clear comparison base.
